Shandong Xinhua Pharmaceutical Company Limited (XIN) — Cash Flow Reinvestment Rate
Shandong Xinhua Pharmaceutical Company Limited (XIN) has a Cash Flow Reinvestment Rate of 2.64x as of September 2023, reinvesting €148.38 Million (capex €80.69 Million plus investments €-67.69 Million) from operating cash flow of €56.11 Million. Check Shandong Xinhua Pharmaceutical Company L (XIN) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Shandong Xinhua Pharmaceutical Company Limited Cash Flow Reinvestment Rate (2013–2025)
Historical reinvestment intensity for Shandong Xinhua Pharmaceutical Company Limited across 13 annual periods. Explore long-term investment intensity of Shandong Xinhua Pharmaceutical Company L to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Shandong Xinhua Pharmaceutical Company Limited (2013–2025)
Year-by-year capital reinvestment analysis for Shandong Xinhua Pharmaceutical Company Limited. For live market cap and broader valuation context, see XIN market cap.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.23x | €125.40 Million | €533.73 Million | €115.60 Million | ▼ -60.8% |
| 2024 | 0.60x | €220.60 Million | €367.61 Million | €212.42 Million | ▼ -74.7% |
| 2023 | 2.38x | €630.24 Million | €265.28 Million | €325.13 Million | ▲ +280.3% |
| 2022 | 0.62x | €473.66 Million | €758.24 Million | €244.76 Million | ▼ -66.8% |
| 2021 | 1.88x | €486.92 Million | €259.12 Million | €249.23 Million | ▲ +154.6% |
| 2020 | 0.74x | €310.19 Million | €420.19 Million | €280.19 Million | ▼ -39.3% |
| 2019 | 1.22x | €423.28 Million | €348.27 Million | €366.51 Million | ▼ -11.6% |
| 2018 | 1.37x | €445.21 Million | €323.91 Million | €388.44 Million | ▲ +82.1% |
| 2017 | 0.75x | €294.31 Million | €389.97 Million | €261.11 Million | ▼ -29.5% |
| 2016 | 1.07x | €470.36 Million | €439.35 Million | €227.07 Million | ▲ +97.0% |
| 2015 | 0.54x | €189.42 Million | €348.64 Million | €169.09 Million | ▼ -32.4% |
| 2014 | 0.80x | €278.23 Million | €346.34 Million | €260.17 Million | ▼ -76.7% |
| 2013 | 3.45x | €362.58 Million | €104.99 Million | €344.53 Million | — |